Brain Mets in HER2-Positive Cancer
- Major impact on morbidity and mortality
- Treatment adaptation (HER2-targeted therapy, kinase inhibitors that cross the blood-brain barrier)+ follow-up, Stereotactic Radiosurgery Guidance, Recurrence Monitoring
- Follow-up of patients diagnosed with brain metastases
- Follow-up of brain metastases & detection of recurrence: difficult today
Direct detection of HER2 positive cells throughout the body, including in the brains.